Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03285607 |
| Title | MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer |
| Recruitment | Withdrawn |
| Gender | |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Washington University School of Medicine |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries |